8th Cell and Gene Therapy Analytical Development Summit
1–3 December 2026 · Boston, Massachusetts, United States · Conference · 45 views
No separate submission deadline recorded. The organiser lists the same date for submissions and the event, so check their site for the real cut-off.
Conference details
- StartsTuesday, 1 December 2026
- EndsThursday, 3 December 2026
- Location Boston, Massachusetts, United States
- FormatConference
- OrganiserHanson Wade
- ContactAnna Westgate-Maher — info@hansonwade.com
- Official site cgt-analytical-development.com/
- Verification Unverified We could not confirm this listing. Verify before paying.
About this conference
Achieving IND and BLA Approvals with Advanced Analytics. Time: 8:00 AM - 5:00 PM. Prices: USD 2299.00 - USD 5297.00. Speakers: Jing Li Director, Clinical Pharmacology and Pharmacometrics, Alexion Pharmaceuticals, and more
Highlights
8th CGT Analytical Development Summit 2026
Full Event GuidePartner With UsRegister Now Landmark approvals from Orca Bio, Rocket Pharmaceuticals, and Regeneron, growing momentum behind in vivo CAR-T and autoimmune cell therapies…
Optimizing Characterization, Delivery Efficiency, & Potency Assay Validation to Demonstrate Product Safety, Quality & Efficacy of Cell & Gene Therapies to Drive Clinical & Commercial Approval
Landmark approvals from Orca Bio , Rocket Pharmaceuticals , and Regeneron , growing momentum behind in vivo CAR-T and autoimmune cell therapies, and new FDA initiatives designed to accelerate individualized genetic medicines are opening exciting opportunities across the industry. Yet these advances are also raising the bar for how therapies are characterized, controlled, and approved.
As novel therapies become more complex and development timelines tighten, analytical development is moving to the center of decision-making . From establishing meaningful potency assays and demonstrating comparability to defining biomarkers and generating robust product characterization data, analytical strategies are increasingly shaping whether programs progress successfully.
The 8th Cell & Gene Therapy Analytical Development Summit is the industry's leading forum dedicated exclusively to analytical development across cell and gene therapy. Bringing together analytical development , QC , characterization , CMC , and regulatory leaders , this is where the community comes together to share practical solutions, benchmark approaches, and stay ahead of evolving scientific developments and regulatory expectations.
For organizations looking to accelerate development, validate their strategies, and uncover proven approaches they can apply immediately, this is the meeting to attend in 2026.
Getting there
Boston, Massachusetts, United States. Open in Google Maps
Details are supplied by the organiser or collected from public sources. Confirm dates, fees and submission requirements on the official site before you travel or pay. No conference can guarantee Scopus or Web of Science indexing in advance — proceedings are assessed after publication. How to spot a predatory conference.
Related conferences
Same subject area and destination, ordered by start date.
Biomarker Operations and Biospecimen Management Summit
74th LISBON World Conference on Chemical, Biological, Agricultural & Environmental Engineering: LCBAEE-26
World Quantum Cannes Festival
2nd Model-Informed Drug Development Summit
4th LNP Characterization and Analytical Development
Never miss a deadline in United States
One email a week with conferences in your field, plus a reminder before each window closes.